- Q1 2024 Seer Inc Earnings Call TranscriptMay 08, 2024$2.23 (+0.90%)Earnings
- Q4 2023 Seer Inc Earnings Call TranscriptFeb 29, 2024$1.82 (+1.11%)Earnings
- Q3 2023 Seer Inc Earnings Call TranscriptNov 07, 2023$1.72 (-2.27%)Earnings
- Seer Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Seer Inc Earnings Call TranscriptAug 08, 2023$4.66 (+0.65%)Earnings
- Q1 2023 Seer Inc Earnings Call TranscriptMay 09, 2023$3.64 (+2.25%)Earnings
- Seer Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Q4 2022 Seer Inc Earnings Call TranscriptMar 02, 2023$4.21 (+7.67%)Earnings
- Seer Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Seer Inc Earnings Call TranscriptNov 08, 2022$6.43 (-8.53%)Earnings
- Seer Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 Seer Inc Earnings Call TranscriptAug 09, 2022$10.27 (-7.81%)Earnings
- Seer Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Seer Inc Earnings Call TranscriptMay 04, 2022$9.04 (+5.98%)Earnings
- Q4 2021 Seer Inc Earnings Call TranscriptFeb 28, 2022$15.32 (+3.79%)Earnings
- Seer Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2022
- Q3 2021 Seer Inc Earnings Call TranscriptNov 09, 2021$35.25 (-3.16%)Earnings
- Seer Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Seer Inc Earnings Call TranscriptAug 12, 2021$29.85 (-0.60%)Earnings
- Seer Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Seer Inc Earnings Call TranscriptMay 10, 2021$32.45 (-14.78%)Earnings
- Q4 2020 Seer Inc Earnings Call TranscriptMar 29, 2021Earnings
Seer Inc at JPMorgan Healthcare Conference Transcript
All right. Good afternoon, ladies and gentlemen. Please take a seat. We're about to get started. I'm Julia Qin, Lead Analyst covering life science tools and diagnostics at JPMorgan, and it's my great pleasure to introduce you to our next company presentation by Seer.
So with that, let me turn it over to Omid. Thank you.
Hello, everyone. Julia, thanks so much and to the JPMorgan team for invitation to be here. I'm Omid Farokhzad, CEO of Seer company. I founded in 2017 -- December of '17 and took public in December of '20. In January of '21, we brought in our flagship product, the Proteograph Product Suite in limited release to customers. And a year ago, this time, we brought the product into a broad commercial release. So today, I'm going to take you through some of the progress we've made over the past year, tell you about some of the commercial traction, what the customers are saying. And then
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)